In recent years, AMP has expanded its work across the Atlantic Ocean to the Americas. In Argentina, we conducted an evaluation of environmental poliovirus circulation during the use of either oral poliovirus vaccine (OPV) or inactivated poliovirus vaccine (IPV).

Further north, in Mexico, we have been working with the Mexican government on a study to determine the incidence of pertussis (whooping cough) among school children between 11 to 16 years of age.

Over in the U.S., we have several long-standing partners, notably the Centers for Disease Control and Prevention (CDC). We first teamed up in the 1980s to develop training in applied epidemiology for both French and African health professionals. More recently, CDC has collaborated with AMP on meningitis surveillance work in sub-Saharan Africa, contributed to the design of the Africhol project (CDC is part of the consortium), and provided technical expertise to the SIVAC Initiative.